These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 29308681)
1. Therapeutic considerations of sarcopenia in heart failure patients. Saitoh M; Ebner N; von Haehling S; Anker SD; Springer J Expert Rev Cardiovasc Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29308681 [TBL] [Abstract][Full Text] [Related]
2. Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms. Cho J; Choi Y; Sajgalik P; No MH; Lee SH; Kim S; Heo JW; Cho EJ; Chang E; Kang JH; Kwak HB; Park DH Cells; 2020 Oct; 9(10):. PubMed ID: 33066240 [TBL] [Abstract][Full Text] [Related]
3. The wasting continuum in heart failure: from sarcopenia to cachexia. von Haehling S Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581 [TBL] [Abstract][Full Text] [Related]
7. Sarcopenia. Tournadre A; Vial G; Capel F; Soubrier M; Boirie Y Joint Bone Spine; 2019 May; 86(3):309-314. PubMed ID: 30098424 [TBL] [Abstract][Full Text] [Related]
8. A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction. Cho MR; Lee S; Song SK J Korean Med Sci; 2022 May; 37(18):e146. PubMed ID: 35535373 [TBL] [Abstract][Full Text] [Related]
9. Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science. Lena A; Anker MS; Springer J Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911600 [TBL] [Abstract][Full Text] [Related]
10. Current and investigational medications for the treatment of sarcopenia. Rolland Y; Dray C; Vellas B; Barreto PS Metabolism; 2023 Dec; 149():155597. PubMed ID: 37348598 [TBL] [Abstract][Full Text] [Related]
11. Muscle wasting and cachexia in heart failure: mechanisms and therapies. von Haehling S; Ebner N; Dos Santos MR; Springer J; Anker SD Nat Rev Cardiol; 2017 Jun; 14(6):323-341. PubMed ID: 28436486 [TBL] [Abstract][Full Text] [Related]
12. Congestive heart failure: what should be the initial therapy and why? Chatterjee K Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993 [TBL] [Abstract][Full Text] [Related]
14. Sarcopenia in heart failure: mechanisms and therapeutic strategies. Collamati A; Marzetti E; Calvani R; Tosato M; D'Angelo E; Sisto AN; Landi F J Geriatr Cardiol; 2016 Jul; 13(7):615-24. PubMed ID: 27605943 [TBL] [Abstract][Full Text] [Related]
15. A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease. Marty E; Liu Y; Samuel A; Or O; Lane J Bone; 2017 Dec; 105():276-286. PubMed ID: 28931495 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia. Sakuma K; Yamaguchi A Pflugers Arch; 2018 Mar; 470(3):449-460. PubMed ID: 29043432 [TBL] [Abstract][Full Text] [Related]
17. Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure. Gage JR; Fonarow G; Hamilton M; Widawski M; MartÃnez-Maza O; Vredevoe DL Neuroimmunomodulation; 2004; 11(3):173-80. PubMed ID: 15067208 [TBL] [Abstract][Full Text] [Related]